Ireland
--:--IST
Latest
Merck's Oral PCSK9 Pill Lipfendra: EU Review and Ireland FDA Tentatively Approves Dr Reddy's Generic Lenacapavir FDA Approves GSK's Hibsago for Chronic Hepatitis B in Adults Wegovy in Ireland: NCPE Backs It, HSE Decision Still Awaited GSK Q3 2026: Falling Vaccine Sales Dent a Strong Quarter Experic Wins HPRA Licence for Kilbeggan Trial Supply Site Merck's Oral PCSK9 Pill Lipfendra: EU Review and Ireland FDA Tentatively Approves Dr Reddy's Generic Lenacapavir FDA Approves GSK's Hibsago for Chronic Hepatitis B in Adults Wegovy in Ireland: NCPE Backs It, HSE Decision Still Awaited GSK Q3 2026: Falling Vaccine Sales Dent a Strong Quarter Experic Wins HPRA Licence for Kilbeggan Trial Supply Site
Clinical Trials in the USA / NCT07900139
Active, not recruiting Observational

A Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026

NCT07900139 · tracked via the Priya Life Science USA tracker
Sponsor
Pfizer
Phase
Observational
Started
2026-07-20
Last updated
2026-10-28

Condition(s) studied

COVID-19 SARS-CoV-2 Infection

Investigational drug(s) / intervention(s)

Patients with COVID-19

Patients with COVID-19: Treatment of Patients with COVID-19 from 2023-2026

Study summary

The purpose of this study is to learn about the management, treatment, healthcare resource utilization (HCRU), and outcomes of individuals with SARS-CoV-2 infection.

This is a retrospective secondary analysis of administrative claims data from 2023-2026, therefore there is no enrollment or participation required. The study will describe and evaluate the real-world management, treatment, HCRU, and outcomes of individuals with SARS-CoV-2 infection.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion * Admitted to the hospital (any cause) * COVID-19 diagnosis

Primary outcome measure(s)

  • Percentage of individuals with COVID-19 by antiviral treatment — Inpatients with COVID-19 between 2023-2026

Trial sites (1)

FacilityCityRegionStatus
Pfizer New York New York New York

More Pfizer trials in the USA

A Study to Learn About How a New Pneumococcal Vaccine Works in Adults Active, not recruiting
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) Active, not recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease Recruiting
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis Active, not recruiting
A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma Recruiting

Other trials for the same condition

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease Recruiting
A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much Money People Spend on Healthcare for COVID-19 Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07900139 on ClinicalTrials.gov ↗ ← All trials in the USA